International Normalized Ratio (INR) Measure at Home Clinical Trial
Official title:
Evaluation of the Impact of Using LabPad® Point-of-care to Measure International Normalized Ratio (INR) at Home on the Patient's Follow up on VKA
This study evaluates the impact of using LabPad® point-of-care to measure International Normalized Ratio (INR) at home on the patient's follow up on vitamine K antagonist (VKA) treatment during 6 months.
The impact of the LabPad® point-of-care use by the nurse will be evaluated in the patients on
vitamine K antagonist (VKA) treatment by measuring the time elapsed between the reading of
the International Normalized Ratio (INR) by the LabPad® at patient's home and the validation
of the biological measure, The time that the patient spends in his therapeutic range will be
measured. The adverse events related to VKA will also be collected. At the end of the study,
the patient will complete satisfaction and usage questionnaires about the LabPad®.
This study will be performed for 6 months.
;